3617-2873 Screening compound: N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-(benzyloxy)benzamide

3617-2873 Screening compound: N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-(benzyloxy)benzamide
3617-2873 Screening compound: N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-(benzyloxy)benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3617-2873
N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-(benzyloxy)benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3617-2873

Molecular Formula

C26H27N3O3 (C26 H27 N3 O3)

Compound Name

N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-(benzyloxy)benzamide

IUPAC name

N-[4-(4-acetylpiperazin-1-yl)phenyl]-4-(benzyloxy)benzamide

SMILES

CC(N(CC1)CCN1c(cc1)ccc1NC(c(cc1)ccc1OCc1ccccc1)=O)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

429.52

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.955

Distribution Coefficient, logD

3.955

Water Solubility, LogSw

-4.13

Polar Surface Area

51.205

Acid Dissociation Constant (pKa)

11.34

Base Dissociation Constant (pKb)

4.16

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

23.10

3617-2873 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Integrin Receptors Targeted library (1715 compounds)

Selective Target Activity Profiling Library (14702 compounds)

Therapeutical Diversity Annotated Library (7563 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
  • Immune system
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Others
  • Phosphatases

References: we are preparing a list of scientific research reports with 3617-2873 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3617-2873?
Check Price and Availability of 3617-2873, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3617-2873 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3617-2873
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3617-2873
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3617-2873 available by request